GSK moves hepatitis B drug into late-stage testing

GSK moves hepatitis B drug into late-stage testing

Submitted by admin on February 2, 2023 - 11:01pm
Source: 
BioPharma Dive
News Tags: 
GSK
bepirovirsen
clinical trials
hepatitis B
Headline: 
GSK moves hepatitis B drug into late-stage testing
snippet: 

GSK said Wednesday it has begun two Phase 3 trials of bepirovirsen, an experimental medicine the British drugmaker hopes may offer a functional cure for hepatitis B.

Do Not Allow Advertisers to Use My Personal information